Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
10/2002
10/01/2002US6458986 Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-α]imidazol-2-one
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/2002
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002US20020137774 Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/25/2002EP1242397A1 Trans olefinic glucokinase activators
09/25/2002EP1242379A1 Curcumin analogues for treating cancer
09/25/2002EP0746312B1 Guanylhydrazones for treating inflammatory conditions
09/24/2002US6455550 N-alkanoylphenylalanine derivatives
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002US6455515 Salicylohydrazide derivatives, processes and intermediates for their preparation, compositions comprising them, and their use
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/24/2002CA2032813C Polyfluoro nitrogen-containing organic compounds
09/19/2002WO2002072536A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
09/19/2002WO2002072534A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
09/19/2002WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
09/19/2002WO2002053534A8 Vla-4 inhibitors
09/19/2002WO2002030876A3 Cyclic carboxylic acids as integrin antagonists
09/19/2002WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
09/19/2002DE10110437A1 Verfahren zur Herstellung von Polyisocyanaten durch Umsetzung von Carbonsäuren mit Isocyanaten, die nach diesem Verfahren hergestellten Produkte und deren Verwendung in Polyurethankunststoffen A process for the preparation of polyisocyanates by the reaction of carboxylic acids with isocyanates, the products prepared by this process and their use in polyurethane plastics
09/19/2002DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/19/2002CA2458479A1 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
09/18/2002EP1241159A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
09/18/2002CN1369496A Use of compound with structure similar to L-phenylalanine as medicine to treat skin diseases
09/17/2002US6452050 Synthesis and use of α-ketoamide derivatives and arrays
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
09/12/2002WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity
09/12/2002WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
09/12/2002US20020128266 ABCA-1 elevating compounds
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128231 Aryl-indane compounds
09/12/2002US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders
09/12/2002US20020125454 Spool valve for controlled dampers
09/12/2002CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity
09/11/2002EP1239200A2 Spool valve for controlled dampers
09/11/2002EP1238993A1 Process for the preparation of polyisocyanates by reaction of carboxylic acids with isocyanates, products prepared by this process and their use in polyurethanes
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP1237548A1 Il-8 receptor antagonists
09/11/2002EP0798291B1 Novel 1,3-dialkylurea derivatives
09/11/2002CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/10/2002US6448442 Contrast media
09/10/2002US6448440 Methods for preparing and using diacyl ureas
09/10/2002US6448402 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/06/2002WO2002068380A1 Synthetic excitatory amino acids
09/06/2002WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides
09/05/2002US20020123596 Polyisocyanates containing acylurea groups, a process for their production and their use
09/05/2002DE10110325A1 Phenylderivate 2 Phenyl derivatives 2
09/04/2002EP1235793A2 Vla-4 integrin antagonists
09/04/2002EP1149066A4 Method of preparing alkylated salicylamides
09/03/2002US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/03/2002US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof
08/2002
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/28/2002EP1233958A1 Inhibitors of histone deacetylase
08/28/2002EP1017734B1 Crosslinkable polyurea polymers
08/27/2002US6441183 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases
08/27/2002CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them
08/22/2002WO2002064549A1 Ppar agonists
08/22/2002WO2002064139A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
08/22/2002WO2002064130A1 Proliferative activator receptor (ppar) compounds
08/22/2002WO2002064128A1 Treatment of diseases characterized by excessive or insufficient cell death
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002CA2438551A1 Ppar agonists
08/22/2002CA2438492A1 Proliferative activator receptor (ppar) compounds
08/21/2002EP1233013A1 Novel phenylalanine derivatives
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/20/2002US6437148 Intermediates for (R)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one
08/15/2002WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002US20020111378 Inhibitors of IMPDH enzyme
08/15/2002US20020111365 Administering protease inhibitor
08/15/2002US20020111364 ABCA-1 elevating compounds
08/15/2002CA2437405A1 Potassium channel openers
08/14/2002EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/13/2002US6433183 (R)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,6-dihydroimidazo[1,2-a]imidazole-2,5-dione
08/13/2002US6432923 Antiinflammatory agents; autoimmune diseases
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2002002518A3 Compounds to treat alzheimer's disease
08/07/2002EP1229010A1 Novel diarylamide derivatives and use thereof as medicines
08/07/2002EP1107949A4 Process for preparing certain phenyl urea compounds
08/07/2002EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
08/07/2002EP0781272B1 Synthesis of penta-substituted guanidines
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/06/2002US6429317 Indane derivatives for antipsychotic compositions
08/01/2002WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 99